These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37850096)

  • 1. The use of liquid chromatography-tandem mass spectrometry in newborn screening for congenital adrenal hyperplasia: improvements and future perspectives.
    de Hora M; Heather N; Webster D; Albert B; Hofman P
    Front Endocrinol (Lausanne); 2023; 14():1226284. PubMed ID: 37850096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing steroid profiling by liquid chromatography-tandem mass spectrometry improves newborn screening for congenital adrenal hyperplasia in New Zealand.
    de Hora MR; Heather NL; Patel T; Bresnahan LG; Webster D; Hofman PL
    Clin Endocrinol (Oxf); 2021 Jun; 94(6):904-912. PubMed ID: 33471388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid profile in dried blood spots by liquid chromatography tandem mass spectrometry: Application to newborn screening for congenital adrenal hyperplasia in China.
    Zhan X; Han L; Qiu W; Gu X; Guo J; Chang S; Wang Y; Zhang H
    Steroids; 2022 Sep; 185():109056. PubMed ID: 35660382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birth Weight- or Gestational Age-adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand.
    de Hora MR; Heather NL; Webster D; Albert BB; Hofman PL
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3390-e3399. PubMed ID: 34058748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
    Janzen N; Peter M; Sander S; Steuerwald U; Terhardt M; Holtkamp U; Sander J
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia.
    Minutti CZ; Lacey JM; Magera MJ; Hahn SH; McCann M; Schulze A; Cheillan D; Dorche C; Chace DH; Lymp JF; Zimmerman D; Rinaldo P; Matern D
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3687-93. PubMed ID: 15292289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid profiling for the diagnosis of congenital adrenal hyperplasia by microbore ultra-performance liquid chromatography-tandem mass spectrometry.
    Feng D; Wang Z; Li H; Shi X; Zou L; Kong H; Xu Z; Yu C; Hu C; Xu G
    Clin Chim Acta; 2023 Mar; 543():117304. PubMed ID: 36958425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
    Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
    J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The High Relevance of 21-Deoxycortisol, (Androstenedione + 17α-Hydroxyprogesterone)/Cortisol, and 11-Deoxycortisol/17α-Hydroxyprogesterone for Newborn Screening of 21-Hydroxylase Deficiency.
    Watanabe K; Tsuji-Hosokawa A; Hashimoto A; Konishi K; Ishige N; Yajima H; Sutani A; Nakatani H; Gau M; Takasawa K; Tajima T; Hasegawa T; Morio T; Kashimada K
    J Clin Endocrinol Metab; 2022 Nov; 107(12):3341-3352. PubMed ID: 36071550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of a steroid profile in heel prick blood using LC-MS/MS.
    Boelen A; Ruiter AF; Claahsen-van der Grinten HL; Endert E; Ackermans MT
    Bioanalysis; 2016; 8(5):375-84. PubMed ID: 26891684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of steroid profiling by UPLC-MS/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience.
    Schwarz E; Liu A; Randall H; Haslip C; Keune F; Murray M; Longo N; Pasquali M
    Pediatr Res; 2009 Aug; 66(2):230-5. PubMed ID: 19390483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplexed steroid profiling of gluco- and mineralocorticoids pathways using a liquid chromatography tandem mass spectrometry method.
    Travers S; Martinerie L; Bouvattier C; Boileau P; Lombès M; Pussard E
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):202-211. PubMed ID: 27339652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of newborn screening protocols for congenital adrenal hyperplasia in preterm infants.
    Sarafoglou K; Gaviglio A; Hietala A; Frogner G; Banks K; McCann M; Thomas W
    J Pediatr; 2014 May; 164(5):1136-40. PubMed ID: 24582106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand.
    de Hora MR; Heather NL; Patel T; Bresnahan LG; Webster D; Hofman PL
    Int J Neonatal Screen; 2020 Mar; 6(1):6. PubMed ID: 33073005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Principal Component Analysis to Newborn Screening for Congenital Adrenal Hyperplasia.
    Lasarev MR; Bialk ER; Allen DB; Held PK
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32525982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot proficiency testing study for second tier congenital adrenal hyperplasia newborn screening.
    De Jesús VR; Simms DA; Schiffer J; Kennedy M; Mei JV; Hannon WH
    Clin Chim Acta; 2010 Nov; 411(21-22):1684-7. PubMed ID: 20619255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirmation of congenital adrenal hyperplasia by adrenal steroid profiling of filter paper dried blood samples using ultra-performance liquid chromatography-tandem mass spectrometry.
    Rossi C; Calton L; Brown HA; Gillingwater S; Wallace AM; Petrucci F; Ciavardelli D; Urbani A; Sacchetta P; Morris M
    Clin Chem Lab Med; 2011 Apr; 49(4):677-84. PubMed ID: 21288182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry.
    Lacey JM; Minutti CZ; Magera MJ; Tauscher AL; Casetta B; McCann M; Lymp J; Hahn SH; Rinaldo P; Matern D
    Clin Chem; 2004 Mar; 50(3):621-5. PubMed ID: 14656905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty Years of Neonatal Screening for Congenital Adrenal Hyperplasia in North-Eastern Italy: Role of Liquid Chromatography-Tandem Mass Spectrometry as a Second-Tier Test.
    Cavarzere P; Camilot M; Palma L; Lauriola S; Gaudino R; Vincenzi M; Antoniazzi F; Teofoli F; Piacentini G
    Horm Res Paediatr; 2022; 95(3):255-263. PubMed ID: 35350013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid steroid hormone quantification for congenital adrenal hyperplasia (CAH) in dried blood spots using UPLC liquid chromatography-tandem mass spectrometry.
    Janzen N; Sander S; Terhardt M; Steuerwald U; Peter M; Das AM; Sander J
    Steroids; 2011 Dec; 76(13):1437-42. PubMed ID: 21839763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.